TRX-cobimetinib
March 10, 2022 at 07:47 AM EST
Travis – Do you know which company holds the patent for TRX-cobimetinib, a cancer tumor drug that shows promise and may be worth a shot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|